GLPwatch
Trials (2139)
Page 16 of 36.
- A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
- GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
- A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus
- ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)
- Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
- Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies
- Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease
- A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
- Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity
- The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
- A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
- A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.
- A Study of TG103 Injection in Type 2 Diabetes Subjects
- GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS)
- Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin
- Effect of Exenatide on Liver and Heart Fat and Inflammation
- Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
- Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid
- A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.
- A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People
- A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy
- Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes
- Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
- A Study of Tirzepatide (LY3298176) in Healthy Participants
- A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
- Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
- Chinese, Overweight or Obesity, Real-World Registry Study
- A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy.
- Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.
- Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin
- Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
- A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia
- Basal Plus GLP1-ra on Glycemic Variability in CKD
- Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users
- The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
- Glutide for Ending Methamphetamine
- Tirzepatide for Alcohol Use Disorder
- Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc
- Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.
- Tirzepatide for the Treatment of Cannabis Use Disorder
- ADJUnct Semaglutide Treatment in Type 1 Diabetes
- Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
- Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)
- Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial
- Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes
- Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?
- A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes
- Clinical Outcomes of Exenatide Versus Basal Insulin
- A Study of IBI362 in Participants With Type 2 Diabetes
- Semaglutide in Treatment of Obesity
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes
- Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes
- Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly
- Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF
- A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
- Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin